Realize Therapeutics Corp.
- Home
- Companies
- Realize Therapeutics Corp.
- Products
- Model LPS - Metabolic Endotoxemia
Model LPS - Metabolic Endotoxemia
Metabolic endotoxemia is a condition estimated to affect 33% of the western world. This occurs when bacterial metabolites such as lipopolysaccharides enter the bloodstream and have been highly correlated to a variety of chronic diseases. That this condition begins with imbalanced intestinal flora makes it particularly susceptible to Realize Therapeutics treatment strategy.